Related Experiment Video
Updated: Mar 29, 2026
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Polymer Nanoparticle-Based Photodynamic Therapy Combined with Immunotherapy for Solid Tumor Treatment
Jieling Lao1, Qiuting Ye1,2, Shijie Fan1,2
1State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Targeting Theranostics Research Center of Guangxi Higher Education, Guangxi Medical University, Nanning 530021, China.
Polymer nanoparticles combined with photodynamic therapy and immunotherapy show promise for solid tumor treatment. This synergistic approach enhances tumor destruction and boosts the body's immune response against cancer.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Immunology
Background:
- Polymer nanoparticles are versatile for tumor treatment due to biocompatibility and multifunctionality.
- Combining photodynamic therapy (PDT) with immunotherapy using polymer nanoparticles is a promising strategy for solid tumors.
Purpose of the Study:
- To review advances in polymer nanoparticle design for photo-immunotherapy.
- To discuss synergistic mechanisms of polymer nanoparticles with immunomodulatory agents.
- To highlight challenges and future perspectives for clinical translation.
Main Methods:
- Systematic review of recent literature on polymer nanoparticles in photo-immunotherapy.
- Analysis of synergistic mechanisms between polymer nanoparticles and immunomodulatory agents (TLR agonists, STING agonists, ICIs).
Main Results:
- Polymer nanoparticles offer a platform for integrating PDT and immunotherapy.
- Combination therapy enhances local tumor ablation and systemic antitumor immunity.
- Synergistic effects observed with immunomodulatory agents like TLR agonists, STING agonists, and ICIs.
Conclusions:
- Polymer nanoparticle-based photo-immunotherapy is a potent strategy for solid tumors.
- Further research is needed to address clinical translation challenges.
- Future perspectives involve optimizing nanoparticle design and combination strategies for enhanced efficacy.
